Morrow G R, Morrell C
N Engl J Med. 1982 Dec 9;307(24):1476-80. doi: 10.1056/NEJM198212093072402.
The nausea and vomiting experienced by one in four cancer patients in anticipation of chemotherapy is probably a learned response to treatment. To determine whether behavioral approaches for altering learned responses might be useful treatments for these symptoms, we compared the effects of "systematic desensitization" (a behavioral treatment in which relaxation is learned as a response to situations in which patients have had anticipatory nausea and vomiting) with those of counseling and of no treatment. Sixty ambulatory cancer patients with anticipatory nausea and vomiting before their third and fourth chemotherapy treatments were randomized equally to the three groups. Significantly more patients receiving desensitization reported no anticipatory nausea before their fifth and sixth chemotherapy treatments than patients given counseling (P less than 0.05) or no treatment (P less than 0.01). Desensitized patients also reported significantly less severe anticipatory nausea (P less than 0.01) and vomiting (P less than 0.05) and a shorter duration of anticipatory nausea (P less than 0.01). We conclude that systematic desensitization appears to have an antiemetic effect in cancer patients who receive chemotherapy, and may be useful in the management of these problems.
四分之一的癌症患者在预期化疗时会出现恶心和呕吐,这可能是对治疗的一种习得性反应。为了确定改变习得性反应的行为方法是否可能是治疗这些症状的有效方法,我们比较了“系统脱敏疗法”(一种行为治疗方法,即让患者学会在预期出现恶心和呕吐的情况下通过放松来应对)与咨询疗法以及不进行治疗的效果。60名在第三次和第四次化疗前有预期性恶心和呕吐的门诊癌症患者被平均随机分为三组。与接受咨询的患者(P<0.05)或未接受治疗的患者(P<0.01)相比,接受脱敏疗法的患者在第五次和第六次化疗前报告无预期性恶心的人数显著更多。脱敏疗法组的患者还报告预期性恶心(P<0.01)和呕吐(P<0.05)的严重程度明显更低,且预期性恶心的持续时间更短(P<0.01)。我们得出结论,系统脱敏疗法似乎对接受化疗的癌症患者有止吐作用,可能有助于处理这些问题。